Related Experiment Videos
Antithrombotic therapy in cardiac disease: an approach based on pathogenesis and risk stratification
V Fuster1, B Stein, J L Halperin
1Mount Sinai School of Medicine, New York, New York.
Insights
This study outlines a strategic approach to managing thrombosis and embolism in cardiovascular diseases. It emphasizes tailoring antiplatelet or anticoagulant therapies based on individual patient risk factors and disease characteristics.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pharmacology
Background:
- Thrombosis and embolism are significant complications in various cardiovascular disorders.
- Understanding the pathogenesis and thromboembolic risk is crucial for effective management.
- Current therapeutic strategies require refinement for optimal patient outcomes.
Purpose of the Study:
- To discuss a structured approach for managing thrombosis and embolism in cardiovascular diseases.
- To formulate rational therapeutic guidelines based on current scientific knowledge.
- To guide the selection of appropriate antiplatelet and anticoagulant regimens.
Main Methods:
- Reviewing current knowledge of thromboembolism pathogenesis and risk assessment.
- Classifying therapeutic considerations by anatomic location (arterial, cardiac chambers, prosthetic valves).
- Stratifying treatment based on pathophysiology (platelet activation, coagulation system activation) and thromboembolic risk level.
Main Results:
- Development of a framework for selecting antiplatelet or anticoagulant therapies.
- Identification of factors influencing the choice between single or combination therapy.
- Personalized treatment strategies for individual patients with cardiovascular disorders.
Conclusions:
- An individualized, risk-stratified approach enhances thrombosis and embolism management.
- Understanding specific patient factors allows for optimized antiplatelet and anticoagulant selection.
- This approach aims to improve therapeutic efficacy and patient safety in cardiovascular care.
Abstract:
An approach to the management of thrombosis and embolism in various cardiovascular disorders is discussed. This approach is based on current knowledge of pathogenesis and risk of thromboembolism. Rational therapeutic guidelines are formulated along the lines of anatomic location (arterial circulation, cardiac chambers or prosthetic valves), pathophysiology (activation of platelets or the coagulation system, or both), and degree of thromboembolic risk. With clear understanding of these factors, it may be possible to determine the most suitable platelet inhibitor or anticoagulant regimen for the individual patient, and whether these agents should be given singly or in combination.